FTO deficiency in older livers exacerbates ferroptosis during ischaemia/reperfusion injury by upregulating ACSL4 and TFRC

Rong Li,Xijing Yan,Cuicui Xiao,Tingting Wang,Xuejiao Li,Zhongying Hu,Jinliang Liang,Jiebin Zhang,Jianye Cai,Xin Sui,Qiuli Liu,Manli Wu,Jiaqi Xiao,Haitian Chen,Yasong Liu,Chenhao Jiang,Guo Lv,Guihua Chen,Yingcai Zhang,Jia Yao,Jun Zheng,Yang Yang

DOI: https://doi.org/10.1038/s41467-024-49202-3

IF: 16.6

2024-06-05

Nature Communications

Abstract:Older livers are more prone to hepatic ischaemia/reperfusion injury (HIRI), which severely limits their utilization in liver transplantation. The potential mechanism remains unclear. Here, we demonstrate older livers exhibit increased ferroptosis during HIRI. Inhibiting ferroptosis significantly attenuates older HIRI phenotypes. Mass spectrometry reveals that fat mass and obesity-associated gene (FTO) expression is downregulated in older livers, especially during HIRI. Overexpressing FTO improves older HIRI phenotypes by inhibiting ferroptosis. Mechanistically, acyl-CoA synthetase long chain family 4 (ACSL4) and transferrin receptor protein 1 (TFRC), two key positive contributors to ferroptosis, are FTO targets. For ameliorative effect, FTO requires the inhibition of Acsl4 and Tfrc mRNA stability in a m6A-dependent manner. Furthermore, we demonstrate nicotinamide mononucleotide can upregulate FTO demethylase activity, suppressing ferroptosis and decreasing older HIRI. Collectively, these findings reveal an FTO-ACSL4/TFRC regulatory pathway that contributes to the pathogenesis of older HIRI, providing insight into the clinical translation of strategies related to the demethylase activity of FTO to improve graft function after older donor liver transplantation.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **The aged liver is more prone to ferroptosis during ischemia - reperfusion injury (HIRI), and the molecular mechanisms behind this phenomenon are explored**. Specifically, the study found that the fat mass and obesity - related gene (FTO) is down - regulated in the aged liver, which leads to an increase in the expression of acyl - CoA synthetase long - chain family member 4 (ACSL4) and transferrin receptor 1 (TFRC), thus exacerbating the ferroptosis phenomenon in the aged liver during HIRI. By inhibiting ferroptosis, the HIRI phenotype of the aged liver can be significantly alleviated. In addition, the study also found that nicotinamide mononucleotide (NMN) can inhibit ferroptosis by up - regulating the demethylation activity of FTO, thereby improving the transplantation function of the aged liver. These findings reveal the role of the FTO - ACSL4/TFRC regulatory pathway in the pathogenesis of aged HIRI, providing a new strategy for improving the graft function after liver transplantation in the aged.